The stock of Marrone Bio Innovations Inc (NASDAQ:MBII) is a huge mover today! About 350,920 shares traded hands or 492.73% up from the average. Marrone Bio Innovations Inc (NASDAQ:MBII) has risen 157.14% since April 5, 2016 and is uptrending. It has outperformed by 155.19% the S&P500.
The move comes after 8 months positive chart setup for the $56.87 million company. It was reported on Nov, 7 by Barchart.com. We have $6.05 PT which if reached, will make NASDAQ:MBII worth $92.13 million more.
Analysts await Marrone Bio Innovations Inc (NASDAQ:MBII) to report earnings on November, 15. They expect $-0.19 earnings per share, up 52.50% or $0.21 from last year’s $-0.4 per share. After $-0.28 actual earnings per share reported by Marrone Bio Innovations Inc for the previous quarter, Wall Street now forecasts -32.14% EPS growth.
According to Zacks Investment Research, “Marrone Bio Innovations Inc. develops environmentally safe bio-based products. The Company specializes in the discovery, development, and marketing of natural products for weed, pest, water resource, and plant disease management. It offers crop protection products for conventional and organic crop production, including herbicides for weed control, fungicides for plant disease control, nematicides for parasitic roundworm control, insecticides for insect and mite killers and plant growth regulators that growers use to increase crop yields, enhance plant health, manage pest resistance, and reduce chemical residues. Marrone Bio Innovations Inc. is headquartered in Davis, California.”
Insitutional Activity: The institutional sentiment increased to 0.88 in Q2 2016. Its up 0.48, from 0.4 in 2016Q1. The ratio improved, as 3 funds sold all Marrone Bio Innovations Inc shares owned while 5 reduced positions. 5 funds bought stakes while 2 increased positions. They now own 10.00 million shares or 0.16% more from 9.98 million shares in 2016Q1.
The New York-based Goldman Sachs Group Inc has invested 0% in Marrone Bio Innovations Inc (NASDAQ:MBII). Morgan Stanley, a New York-based fund reported 480 shares. Creative Planning owns 500 shares or 0% of their US portfolio. Waddell Reed Financial owns 4.77 million shares or 0.01% of their US portfolio. Vanguard Gru Inc last reported 406,840 shares in the company. Bridgeway Cap Mngmt Inc holds 0% or 181,200 shares in its portfolio. Retail Bank Of New York Mellon last reported 0% of its portfolio in the stock. Ardsley Advisory Partners has invested 0.08% of its portfolio in Marrone Bio Innovations Inc (NASDAQ:MBII). Architects Inc accumulated 1,500 shares or 0% of the stock. Kcg holds 0% or 10,167 shares in its portfolio. The Florida-based Ladenburg Thalmann Ser has invested 0% in Marrone Bio Innovations Inc (NASDAQ:MBII). Retail Bank Of America De last reported 0% of its portfolio in the stock. Northern Tru Corp holds 0% of its portfolio in Marrone Bio Innovations Inc (NASDAQ:MBII) for 21,816 shares. Evanson Asset Mngmt has 0.01% invested in the company for 26,000 shares. State Street holds 0% of its portfolio in Marrone Bio Innovations Inc (NASDAQ:MBII) for 10,800 shares.
More notable recent Marrone Bio Innovations Inc (NASDAQ:MBII) news were published by: Marketwatch.com which released: “Marrone Bio Innovations Inc.” on September 17, 2013, also Bizjournals.com with their article: “Marrone Bio’s loss narrows as sales rise 50 percent” published on August 09, 2016, Businesswire.com published: “Marrone Bio Innovations Announces Agreement to Settle Class Action Litigation” on May 26, 2016. More interesting news about Marrone Bio Innovations Inc (NASDAQ:MBII) were released by: Bizjournals.com and their article: “Feds arrest former executive at Marrone Bio Innovations for securities fraud” published on February 17, 2016 as well as Businesswire.com‘s news article titled: “Marrone Bio Innovations, Inc. Reports 2015 Fourth Quarter and Full Year Results” with publication date: March 30, 2016.
MBII Company Profile
Marrone Bio Innovations, Inc., incorporated on June 15, 2006, offers bio pest management and plant health products. The Company’s bio products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. The Company’s four crop protection product lines include Regalia, Grandevo, Zequanox, Venerate and Majestene. The Company’s products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It also offers Regalia for large-acre row crops, such as corn and soybeans.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.